Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844)
- PMID: 28938930
- DOI: 10.1016/j.ophtha.2017.05.007
Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844)
Comment in
-
Reply.Ophthalmology. 2017 Oct;124(10):e75. doi: 10.1016/j.ophtha.2017.05.001. Ophthalmology. 2017. PMID: 28938932 No abstract available.
Comment on
-
Bevacizumab for Retinopathy of Prematurity: Treatment When Pathology Is Embedded in a Normally Developing Vascular System.Ophthalmology. 2016 Sep;123(9):1843-4. doi: 10.1016/j.ophtha.2016.06.054. Ophthalmology. 2016. PMID: 27549875 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources